Pete Davidson Took Ketamine For 4 Years Before Rehab
Pete Davidson is opening up about the drugs he used before he checked himself into a rehab facility three months ago. When the Bupkis star began undergoing treatment in June,…
Pete Davidson at the 2023 NFL Pro Bowl Games at Allegiant Stadium on February 05, 2023 in Las Vegas, Nevada.
Ethan Miller/Getty ImagesPete Davidson is opening up about the drugs he used before he checked himself into a rehab facility three months ago. When the Bupkis star began undergoing treatment in June, Page Six reported he was being treated for PTSD and borderline personality disorder. In 2018, Davidson revealed that he had been diagnosed with borderline personality disorder after years of battling depression and anxiety. The disorder's symptoms led him to check into rehab in 2016. At that time, he believed the mental breakdowns he was experiencing came from smoking cannabis.
Speaking to Variety in 2018, Davidson said he’d “been in and out of mental health facilities” since he was 9. He said the new medication he was on stabilized him after the “last few years have been real rough with me.” He added, “I took all these mental health classes and really spent a lot of time getting me good.”
During his recent comedy show tour alongside John Mulaney and Jon Stewart in Atlantic City over the weekend, Pete spoke about what sent him to rehab. According to the New York Post, he said he was using his cat’s ketamine. Per People, he told the audience he took the dissociative anesthetic daily for four years. "It was magical," the 29-year-old said of his experience. "I am fresh out of rehab, everyone," he added. "I got that post-rehab glow. Seventh time's the charm!" Also in his set, Pete joked, "One time, I got The Wiggles to mesh with Schindler's List," People reported.
RELATED: Pete Davidson To Do Community Service After Reckless Driving
Though Ketamine is also used as a treatment for depression, a pain management tool, and a recreational drug, it isn't FDA-approved for treating any psychiatric disorder. However, in 2019, the FDA approved the "S" form of the drug. This form is derived from ketamine as a nasal spray for "treatment-resistant depression in adults." According to the DEA, ketamine has some hallucinogenic effects and "induce a state of sedation (feeling calm and relaxed), immobility, relief from pain, and amnesia (no memory of events while under the influence of the drug)."
